PharmaBoardoom media partner of biggest ever CPhI Worldwide
CPhI Worldwide 2014, held this year in Paris, was the largest ever event held by the organizers, with more than 36,000 attendees and 2,500 exhibitors. PharmaBoardroom was a media partner…
Address: Immeuble le Volta 17-19 rue Jeanne Braconnier, Meudon-la-foret, 92360 france
Tel: 0 805 54 02 98
Web: http://www.hospira.fr/default.aspx
Hospira is a specialty pharmaceutical and medication delivery company driven by its vision of Advancing Wellness through the right products and people. With generic, specialty and biosimilar business lines, it is dedicated to bringing the right products to the people who need them.
Hospira’s presence in France was greatly increased with the acquisition of Mayne Pharma in 2007 which has since proved a successful move and has led to double digit growth rates within the country. With a self-described ‘start-up’ mentality and penchant for efficient business, Hospira France is committed to similar growth in the years ahead while meeting the needs of the local market.
Injectable Pharmaceutical Focus:
Oncology
Acute-Care
Medical Devices:
Medication Management Systems
CPhI Worldwide 2014, held this year in Paris, was the largest ever event held by the organizers, with more than 36,000 attendees and 2,500 exhibitors. PharmaBoardroom was a media partner…
You worked for many years in emerging markets, especially in Latin America, but also in neighbor countries such as Spain. How these previous experiences in very different markets can now…
In the wake of the most recent CSIS meeting, LFB and Sanofi-Aventis announced the intention to collaborate in bioproduction. What are the terms to this agreement and what are the…
We have had the chance to interview a number of Teva’s subsidiaries in Europe, and witnessed how each of them has dealt with the strong transformations that the group has…
Historically, UCB Pharma had a much more ‘traditional’ approach to the industry with a broader scope of operations. Recently, the company reoriented in the direction of biopharmaceuticals by moving away…
Nycomed lost an important patent with Pantoprazole in the middle of 2009, which has undoubtedly warranted some restructuring. What has been the impact of this loss on business in France,…
BMS recently announced divesting from their facilities in Epernon and Meymac but at the same time reinforcing manufacturing in Agen. Could you speak to strategy of this restructuring within France…
Novo Nordisk just celebrated 50 years in France; what have been some of the more recent events that have marked the affiliate’s time here? If you look from the perspective…
Baxter is approaching 40 years in France, what have been the major milestones of the group during this period and what is the importance of France to the group? During…
Sandoz has set important trends in the pharmaceutical market, first by creating a leading global generics business under the umbrella of parent company Novartis, and secondly by investing heavily in…
How would you define the Institut Pasteur’s relationship with the pharmaceutical industry and how it has evolved in recent years? Since its foundation 120 years ago, the Institut Pasteur has…
Nordic Pharma has been established in the French market since 2002 as one of its first steps towards internationalization. What have been the main milestones and achievements of Nordic in…
See our Cookie Privacy Policy Here